Ad is loading...
MENU
SGMO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Sangamo Therapeutics (SGMO) Ownership - Who owns Sangamo Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
501 Canal Boulevard
Phone
+1 510 970-6000
Employees
405
Web
https://www.sangamo.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
427.67M
P/E Ratio
N/A
Total Cash
27.79M
Projected Growth
N/A
Total Debt
29.1M
Revenue
12.28M
Risk (Beta)
1.24
Dividend Yield
N/A
Total Cash/Share
0.13
Total Debt/Equity
N/A
Revenue/Share
0.27 USD as % of share price
Fundamentals
SGMO
Capitalization
428M
P/E Ratio
N/A
Risk (Beta)
1.24
Dividend Yield
N/A
Total Cash
27.8M
Total Cash/Share
0.13
Total Debt
29.1M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.27%
Revenue
12.3M
ROE
N/A
Book Value
23.7M
P/B Ratio
10.93
Cash Flow
N/A
Earnings
-1.38
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2.08M
Current Ratio
1.03
Current Revenue Per Employee
879.01
Dividends Per Share - Security
N/A
EBITDA
-190.93M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-119.44
Shares Held By Institutions
50.4M
Shares Outstanding - Current
209M
Total Liabilities
69.3M
Total Volume MTD
N/A
Value
-1
Gain YTD
277.324
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of transcription factors in the regulation of genes
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
501 Canal Boulevard
Phone
+1 510 970-6000
Employees
405
Web
https://www.sangamo.com